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Introduction
Abnormal valve development is a common human congenital
anomaly, affecting approximately 1% of all live births
(Armstrong and Bischoff, 2004; Barnett and Desgrosellier,
2003). Because of its prevalence, it is important to understand
the mechanisms underlying cushion and valve development.
During early heart development, a subset of endocardial cells
break homotypic cell adhesive contacts, undergo cytoskeletal
changes and invade the matrix-rich cardiac jelly to form
endocardial cushions (Armstrong and Bischoff, 2004;
Eisenberg and Markwald, 1995). The localized nature of the
epithelial to mesenchymal transition (EMT) suggests a
mechanism to molecularly distinguish the myocardium and/or
endocardium of the atrioventricular (AV) canal from the rest of
the non-cushion-forming heart. The signals that induce EMT
have been investigated in chick embryos using a three-
dimensional collagen gel invasion assay (Runyan and
Markwald, 1983). Data from these experiments revealed that
Tgf2 and Tgf3 perform crucial and sequential functions in
cushion morphogenesis. In chick embryos, Tgf2 is thought to
mediate the activation of endocardium, while Tgf3 functions
in mesenchymal invasion (Camenisch et al., 2002).
In mouse embryos, the signals that induce EMT are less well
understood. Data from the in-vitro collagen gel assays
suggested that Tgf2 is the signal required for EMT; however,
mice homozygous for a null allele of Tgf2 still make
cushions, indicating that other signals are required in vivo to
induce EMT in mammals (Bartram et al., 2001; Camenisch et
al., 2002; Sanford et al., 1997). Notch signaling, through
regulation of the Snai1 (previously Snail) repressor, has
recently been shown to be required for cushion formation
through downregulation of vascular/endothelial-cadherin (VE-
cadherin) in cushion endocardium (Timmerman et al., 2004).
In zebrafish, Wnt signaling has been implicated in the EMT
required for valve formation (Hurlstone et al., 2003). However,
mice with an endocardial-specific deletion of -catenin have
cushions, although defective, suggesting that Wnt signaling is
not essential for EMT in mammals (Liebner et al., 2004).
In addition to providing a signal to the endocardium for AV
cushion formation, the AV myocardium is phenotypically
distinct from the chamber myocardium. Chamber myocardium
is coupled intercellularly, has a fast contraction pattern and
expresses the chamber-specific genes Cx40 (Gja5 – Mouse
Genome Informatics), Anf (Nppa – Mouse Genome
Informatics) and chisel (Smpx – Mouse Genome Informatics).
By contrast, the smooth-walled myocardium of the AV canal
retains an embryonic phenotype and fails to express genes that
are found in the chamber myocardium (Habets et al., 2002).
T-box (Tbx) genes have been implicated in regional
patterning of the myocardium (Plageman and Yutzey, 2005).
Tbx2 has been shown to repress expression of chamber-specific
genes in the AV myocardium. Mice with a Tbx2 loss-of-
function have expansion of chamber-specific genes into the AV
myocardium (Harrelson et al., 2004). Moreover, Tbx2 has been
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shown to bind to an element in the Anf gene that represses Anf
expression in AV myocardium through competition with Tbx5
(Habets et al., 2002). In other experiments, Tbx20 has been
shown to directly repress Tbx2, indicating that a Tbx gene
regulatory network functions to regionally pattern the
myocardium (Cai et al., 2005; Singh et al., 2005; Stennard et
al., 2005; Takeuchi et al., 2005).
Previous data revealed that Bmp2 is expressed in the AV
myocardium at 9.5 and 10.5 days post coitum (dpc) and in the
cushion mesenchyme at later stages (Lyons et al., 1990; Sugi
et al., 2004). Moreover, gene inactivation studies in mice
revealed that Bmp2 was necessary for early myocardial
development (Zhang and Bradley, 1996). Bmp2 has been
suggested to have a role in valve morphogenesis in mouse
embryos, based on data from the collagen gel invasion assay
(Sugi et al., 2004). In that work, Bmp2 could substitute for
myocardium to induce endocardial EMT. Moreover, noggin
treatment of explants efficiently inhibited EMT. However,
other data indicated that Bmp2 was insufficient to induce EMT
on its own but could enhance Tgf transformation activity
(Yamagishi et al., 1999).
Here, we provide strong genetic evidence that Bmp2 induces
AV cushion EMT in mammals. We inactivated Bmp2
specifically in the AV myocardium and found that Bmp2
mutant embryos failed to form AV cushions. Expression of
Has2 was decreased in Bmp2 mutant embryos with reduced
formation of the cardiac jelly. Furthermore, inactivation of the
Bmp type 1A receptor, Bmpr1a, in endocardium also resulted
in loss of AV cushion formation, indicating that Bmp2 signaled
directly to the endocardial cushions. Our findings also indicate
that the basic helix-loop-helix (bHLH) transcription factor
Twist1 is a downstream effector of Bmp2 in EMT. We also
found that Bmp2 has a planar signaling function to regulate
patterning of the AV myocardium through regulation of Tbx2
expression. Taken together, our data indicate that Bmp2 has a
crucial function in coordinating cushion morphogenesis with
AV myocardial patterning.
Materials and methods
Generation of the Bmp2floxneo and Bmp2null alleles
The Bmp2floxneo allele has been described (Ma and Martin, 2005). The
Bmp2floxneo allele contains LoxP sites flanking Bmp2 exon 3 that
encodes the mature peptide. Deletion of this exon was shown to result
in a null Bmp2 allele. To generate the Bmp2null allele, we used the
NestinCre transgene, which directs efficient cre activity in the
germline (Trumpp et al., 1999). For genotyping, DNA was extracted
from yolk sacks or tails of embryos and adult mice, respectively. PCR
was used to determine the genotype of the Bmp2null allele with the
primers (5-AAG TCT CCT CCT TCA TCA GTA TAC GCT CG-3)
and (5-GAT ATC GAA TTC GAT ATC AAG CTG AT-3) located in
the neomycin cassette. The amplified product is 100 bp.
Whole-mount in-situ hybridization
Whole-mount and section in-situ hybridization was performed as
previously described (Lu et al., 1999). Details about probes will be
provided upon request. In all in-situ experiments, at least three
mutants and three control embryos were analyzed for each
experiment.
lacZ staining and histology
For histology, embryos were fixed overnight in Bouin’s fixative or
buffered formalin, dehydrated through graded ethanol and embedded
in paraffin. Sections were cut at 7-10 m and stained with H&E.
Staining for lacZ was as previously described (Lu et al., 1999).
Immunohistochemistry
Tissue sections were deparaffinized, rehydrated and boiled for 5
minutes in 10 mmol/l sodium citrate for antigen retrieval. After
washing in PBS, the nuclear factor of activated T-cells (NFAT) c1
(Cat. No.: 56602; BD Pharmingen, San Jose, CA 95131, USA)
primary antibody (1:250 dilution), was applied and incubated
overnight at 4°C. The sections were washed and incubated
consecutively with biotin-labeled secondary antibody (sc-2017; Santa
Cruz, CA 95060 USA). The secondary antibodies were detected using
the avidin-biotin method. To detect Phospho-Smad1/Smad5/Smad8,
sections were blocked in PBS/0.05% BSA and primary antibody
(#9511; Cell Signaling, MA 01915, USA) was applied with 1:200
dilution for overnight at 4°C. Sections were washed and incubated
with secondary antibody (Cat. No.: DPVR-15DAB). Color was
developed with diaminobenzidine (DAB) provided by the kit of
secondary antibody and the sections were counterstained with
hematoxylin. For control staining, preimmune serum was used instead
of the primary antibody.
Results
Bmp2 has a dynamic expression pattern in the heart
Bmp2 expression was examined by whole-mount in-situ
hybridization with a Bmp2 exon3 probe (Fig. 1). Bmp2 was
detected in the cardiac crescent at 7.5 dpc, consistent with its
role in early cardiac morphogenesis (Fig. 1A) (Schultheiss et
al., 1997; Zhang and Bradley, 1996). At 8.5 dpc, Bmp2 was
expressed bilaterally in the sinus venosus (Fig. 1B,C), while at
9.5 and 10.5 dpc, Bmp2 was abundantly expressed in the AV
myocardium and at lower levels in the outflow tract (OFT; Fig.
1D,E,F,G). In the 11.5 dpc embryo, Bmp2 mRNA expression
in the AV canal was extinguished, although low-level
expression was still detected in the OFT and ventricular
myocardium (Fig. 1H). By 12.5 dpc, Bmp2 expression was
detected at low levels in the OFT and left ventricular
myocardium (Fig. 1I). Taken together, these data indicate that,
in addition to an early role in cardiac induction, Bmp2 also
probably functions in the development of the inflow and AV
canal. Bmp2 also may have a role in OFT and ventricular
myocardial development.
Inactivation of Bmp2 in the AV myocardium
To directly investigate Bmp2 function in cardiac development,
we constructed a Bmp2 conditional null allele, the Bmp2floxneo
allele, which contained LoxP sites surrounding exon 3
encoding the mature Bmp2 peptide. Deletion of exon 3 has
been shown to result in a Bmp2 null allele (Ma and Martin,
2005). To inactivate Bmp2 in the heart, we used the Nkx2.5cre
knock-in allele, which directs cre activity to the anterior
splanchnic mesoderm of the primary heart field and within the
mature heart (Fig. 2A,B) (Liu et al., 2004; Moses et al., 2001).
To generate Bmp2 cardiac-specific mutant embryos, we
crossed the Nkx2.5cre+/– mice to the Bmp2floxneo+/– mice to
obtain Nkx2.5cre; Bmp2floxneo compound heterozygotes.
Intercrosses between these mice and the Bmp2floxneo
homozygous mice resulted in recovery of 25% of embryos that
were Nkx2.5cre; Bmp2floxneo/floxneo(f/f), hereafter referred to as
Bmp2 CKO. This crossing strategy required that both
Bmp2floxneo alleles undergo cre-mediated recombination to
generate a Bmp2 null cell. Because there is a delay in the timing
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of cre-mediated recombination as intracellular cre protein
accumulates, we predicted that the two-allele recombination
strategy would result in a slight delay in Bmp2 cardiac
inactivation (Nagy, 2000). This would provide a stable genetic
system to study Bmp2 in either the sinus venosus or the AV
canal.
To determine the timing and extent of the Bmp2 cardiac-
specific deletion, we performed whole-mount analysis with the
Bmp2 exon 3 probe that is deleted in the Bmp2 CKO mutant
embryos. In wild-type and Bmp2 CKO mutant embryos,
expression of Bmp2 exon 3 was readily detectable bilaterally
in the sinous venosus at 8.5 dpc (Fig. 2C,D). However, by 9.0
dpc Bmp2 was undetectable in AV myocardium of Bmp2 CKO
mutant embryos (Fig. 2E,F). At 9.5 dpc, Bmp2 exon 3 was
absent in the AV myocardium and formation of the AV
cushions was disrupted in the Bmp2 CKO embryos (Fig. 2G-
Fig. 1. Bmp2 expression pattern
during cardiogenesis. Whole-
mount in-situ hybridization with
Bmp2 exon3 probe shows Bmp2
expression pattern (A-I). At 7.5
dpc, Bmp2 expression can be
visualized bilaterally in the
primitive heart tube (A,
indicated by arrows). Side view
(B) and frontal view (C),
indicating that at 8.5 dpc Bmp2
is expressed in the sinus
venosus. At 9.5 dpc, both lateral
view (D) and frontal view (E)
showed that Bmp2 is highly
expressed in the myocardium of
the AV canal, as well as lower
level of expression in the
outflow tract (indicated by
arrows). (F,G) Side view and
frontal view, showing that at 10.5 dpc Bmp2 expression is maintained in the myocardium of the AV cushion region and in the outflow tract
(arrows). At 11.5 and 12.5 dpc, Bmp2 expression decreased significantly, as denoted by arrows (H,I). A, atrium; LA, left atrium; LV, left
ventricle; OFT, outflow tract; RA, right atrium; RV, right ventricle; V, ventricle.
Fig. 2. Nkx2.5Cre activity and tissue-specific inactivation of Bmp2
in mouse embryos. (A) At 8.5 dpc, Nkx2.5Cre activity is
visualized throughout the heart (ventral view in A). (B) At 9.5 dpc,
parasagittal sections indicated there is intense -gal activity in
both myocardium (arrow) and endocardium (arrowhead). (C-J). In-
situ analysis using Bmp2 exon 3 as a probe, showing that at 8.5
dpc Bmp2 is expressed in the sinus venosus in the wild-type
embryo (arrow, C) and is still expressed in the mutant (arrow, D).
At 9.0 dpc (E,F) and 9.5 dpc (G,H,I,J), Bmp2 is highly expressed in the myocardium of the control AV canal (arrow, E,G,I) but is absent in the
Bmp2 CKO mutant (arrow, F,H,J). I and J are parasagittal sections of embryos in G and H. (K,L) Immunohistochemistry of phospho-
Smad1/5/8, effectors of Bmp signaling, indicating Bmp-responding cells in the endocardium (denoted by arrow) and myocardial cells
(arrowhead) of the AV canal at 9.5 dpc (K). In the Bmp2 CKO mutant, the phospho-Smad 1/5/8 signal is reduced in both cell populations (L). a,
atrium; ba, branchial arch; fn, fronto-nasal process; hf, head fold; sv, sinus venosus; v, ventricle.
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J). These data indicate that the early expression of Bmp2 is
intact in the Bmp2 CKO embryos but by 9.0 dpc, Bmp2
expression in the AV myocardium is absent, allowing us to
focus on Bmp2 function in the AV canal.
Bmp2 signals directly to the cushion endocardium
To establish functionally that Bmp signaling had been
disrupted in the Bmp2 CKO mutant embryos, we performed
immunostaining with an antibody that recognizes P-Smad
1/5/8. Smad 1, Smad 5 and Smad 8, the receptor regulated (R-
Smad) effector molecules for Bmp signaling, are
phosphorylated by a ligand-bound receptor complex.
Phosphorylation of the Bmp-dependent R-Smad is an
indication that cells are actively receiving a Bmp signal. In the
9.5 dpc wild-type embryos, approximately 80% of endocardial
cells in the AV canal were stained for P- Smad1/5/8 (Fig. 2K).
We also noted that approximately 10-15% of the AV
myocardium was positive for Smad 1/5/8 immunostaining. By
contrast, in the Bmp2 CKO mutant embryos, Smad 1/5/8-
positive cells were drastically reduced in the endocardium, and
only a few scattered cells in the AV myocardium were
immunoreactive (Fig. 2L). From these data, we conclude that
Bmp signaling to the AV cushion-forming endocardium is
severely disrupted in the Bmp2 CKO embryos at 9.5 dpc, while
Bmp signaling in the AV myocardium is significantly reduced.
Embryonic lethality and AV cushion defects in the
absence of Bmp2 in the AV myocardium
Analysis of litters at embryonic time points revealed that Bmp2
CKO mutant embryos were indistinguishable from wild-type
littermates at 8.5 and 9.0 dpc. At 9.5 dpc, Bmp2 CKO mutant
embryos had abnormal morphology of the AV canal
constriction but were still recovered at Mendelian frequencies
(Table 1). By 10.5 dpc, all Bmp2 CKO mutants exhibited
pericardial effusion and growth retardation, indicating that
these embryos suffered from heart failure at this stage.
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Fig. 3. Severe AV cushion defects in Bmp2 CKO mutant embryos.
Parasagittal sections through heart of wild type (A,B) and Bmp2 CKO
mutant (C,D) at 9.5 dpc, showing that mesenchymal cells are absent in
the AV cushion (arrows). Panels B and D are high power images of A
and C. (E,F) Parasagittal sections at 10.5 dpc, showing lack of AV
cushion mesenchyme in the Bmp2 CKO mutant (arrows). Also note the
severely compromised myocardium in the mutant heart. (G-J) In-situ
hybridization indicated that Msx2 is expressed in the AV myocardium
and migrating mesenchymal cells (arrow, G), but its expression is diminished in the mutant (arrow, H). Panels I and J are parasagittal sections
of embryos in G and H, showing lack of Msx2 expression in the mutant (arrows). (K-N) Has2, encoding an extracellular matrix protein, is
present in the AV myocardium (arrow) and migrating mesenchyme (arrowhead) in the 9.5 dpc wild-type embryos (K,M) but is reduced in the
Bmp2 CKO myocardium (L,N). M and N are parasagittal sections of K and L. a, atrium; ba, branchial arch; v, ventricle.
Table 1. Embryo recovery: Nkx2.5Cre;Bmp2f/+  Bmp2f/f intercrosses
Stage (dpc) Nkx2.5Cre;Bmp2f/+ Bmp2f/+ Bmp2f/f Nkx2.5Cre;Bmp2f/f Mutant
8.5-9.0 21 23 18 31 33%
9.5 144 136 171 170 27%
10.5 6 11 2 12 38%
12.5-birth 18 17 10 0 0%
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Histological analysis revealed there was no discernible
abnormality in cardiac structure at 8.5 dpc in the Bmp2 CKO
mutant embryos (data not shown, see Fig. 5A,B). However at
9.5 dpc, all Bmp2 CKO mutant embryos had severe defects in
AV cushion morphogenesis (Fig. 3A-D). In the wild-type
embryos, there was expansion of the space between myocardium
and endocardium as the cardiac jelly was laid down by the AV
myocardium (Krug et al., 1985). However, in the Bmp2 CKO
mutant embryos the space between the myocardium and the
endocardium failed to expand in 43% (10 of 23) of the 9.5 dpc
Bmp2 CKO mutant embryos, indicating a defect in cardiac jelly
formation (Fig. 3A-F,I-J). We noted that the expression of Has2,
a crucial component of the cardiac jelly, was reduced in the
Bmp2 CKO mutant myocardium (see below).
In wild-type embryos, migrating mesenchymal cells were
observed in the forming AV cushions at 9.5 dpc (Fig. 3A,B).
Parasagittal sections through Bmp2 CKO mutant embryos
indicated that the invasive mesenchyme failed to form (Fig.
3C,D). The failed EMT phenotype was observed in all Bmp2
CKO mutant embryos, including embryos with cardiac jelly
deposition, suggesting that the EMT defect was probably not
secondary to cardiac jelly loss (Fig. 3C,D). Analysis of Has2
and Msx2, markers of the transformed, migrating mesenchyme,
revealed that the endocardium had not been induced to undergo
EMT (Fig. 3G-N). Taken together, these data indicate that
Bmp2 is required to both promote cardiac jelly formation and
induce AV endocardial EMT.
Inactivation of Bmpr1a in the endocardium disrupts
endocardial cushion formation
In order to establish more firmly that Bmp2 signaled directly
to the underlying endocardium, we generated mouse embryos
that were deficient in the competence to receive Bmp signals
within the endocardium. We inactivated the type 1A Bmp
receptor, Bmpr1a, in the endocardium using the Tie2 cre
transgenic line (Kisanuki et al., 2001). Bmpr1a is a major type
1 receptor for Bmp2 and Bmp4 (von Bubnoff and Cho, 2001).
Because germline mutation of Bmpr1a is early embryonic
lethal, we used the Bmpr1a conditional null (Bmpr1aflox) allele
(Mishina et al., 2002; Mishina et al., 1995). We generated
embryos that carried Tie2cre and the Bmpr1aflox and Bmpr1anull
(Bmpr1an/f) alleles. We examined Tie2cre; Bmpr1an/f mutant
embryos at 9.5 dpc and found that embryos deficient for
Bmpr1a in the cushion endocardium failed to form cushions
(Fig. 4A,B). It is notable that one-third of Tie2cre; Bmpr1an/f
mutants made cushions. This probably results from variability
of cre activity; however, it is possible that other type 1 receptors
also have a function in the cushion endocardium.
Fig. 4. Defective EMT in the Tie2Cre; Bmpr1a n/f mutant embryos.
(A,B) Histologic analysis of wild-type (A) and Tie2Cre; Bmpr1a n/f
mutant (B) embryos, showing lack of migrating mesenchymal cells
in the AV cushion region at 9.5 dpc (arrows).
(C,D) Immunohistochemistry of phospho-Smad1/5/8, showing Bmp-
responsive endocardium in the control embryo (arrows in C). In the
mutant, endocardium with no phospho-Smad1/5/8 (arrows in D) or
reduced phospho-Smad1/5/8 is shown (D, arrowhead). (E-N) Whole-mount in-situ hybridization analysis with Twist1 (E,F), VE-cadherin (G-J),
Notch1 (K,L) and Snai1 (M,N). Genotypes are shown, and arrows denote hybridization signal. a, atrium; ba1, first branchial arch; ba2, second
branchial arch; v, ventricle.
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To determine the extent of Bmpr1a inactivation in the
Tie2cre; Bmpr1an/f mutants, we examined Smad 1/5/8
immunostaining in the AV endocardium of wild-type and
Bmpr1a mutant embryos. In the wild type, most endocardial
cells stained positive for P-Smad 1/5/8 (Fig. 4C), while in the
Tie2cre; Bmpr1a mutant embryos approximately 50% fewer
strong positive cells were detected (Fig. 4D). We noted that the
main reduction in P-Smad 1/5/8 immunoreactivity in Tie2cre;
Bmpr1a mutants was in endocardium located toward the atrium
(Fig. 4D, n=3). The significance of this observation is presently
unclear. These data indicate that while endocardial inactivation
of Bmpr1a results in incomplete loss of endocardial Bmp
responsiveness, the AV cushion phenotype is strong, revealing
that AV cushion EMT is very sensitive to small decreases in
Bmp signaling. Moreover, our findings support the hypothesis
that other type 1 receptors may have overlapping function in
the AV canal endocardium.
We studied expression of Twist1, encoding a bHLH
transcription factor that is expressed in AV endocardium and
has been implicated in EMT in cancer metastasis (Yang et al.,
2004). In wild-type embryos, we found that Twist1 was
expressed in both AV endocardium and cushion mesenchyme
(Fig. 4E and see Fig. 5E,G). In the Tie2cre; Bmpr1an/f mutant
AV canal, we found that Twist1 expression was reduced at 9.5
dpc and absent by 10.5 dpc (Fig. 4F).
Twist has been shown to negatively regulate expression of
E-cadherin in breast cancer cells, prompting us to examine
expression of VE-cadherin in the AV canal endocardium of
Tie2cre; Bmpr1an/f mutant embryos (Kang and Massague,
2004). During EMT, VE-cadherin is normally downregulated
(Fig. 4G,I); however, in the Tie2cre; Bmpr1an/f mutant
endocardium VE-cadherin expression persisted when
compared with the wild-type embryo (Fig. 4H,J). Notch
signaling has been shown to be required for EMT in the AV
canal (Timmerman et al., 2004). In the Tie2cre; Bmpr1a
mutants, we found that expression of Notch1 was similar to
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Fig. 5. Defective
endocardium in Bmp2 CKO
mutant embryos.
Immunohistochemistry of
NFATc1 in wild-type (A)
and Bmp2 CKO mutant (B)
embryos at 8.5 dpc. At 9.5
dpc, there is upregulation of
NFATc1 expression in the
AV cushion endocardium
(C) in wild-type embryos
but in the Bmp2 mutant
many of the endocardial
cells are negative and there
is no regional specificity of
the signal (D). Arrows
denote positively stained
cells. Whole-mount in-situ
hybridization followed by
sectioning for some probes
with Twist1 (E-H), Msx1 (I-
L), Smad6 (M,N), VE-
cadherin (O,P), Notch1 (Q-
T) and Snai1 (U,V) probes
at 9.5 dpc in wild-type and
Bmp2 CKO mutant
embryos. Arrows denote
positive hybridization signal
or areas where signal is up-
or downregulated in the
mutant embryo. Probes and
genotypes are labeled. a,
atrium; ba1, first branchial
arch; v, ventricle.
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wild-type embryos (Fig. 4K,L). We also examined expression
of Snai1, a zinc finger transcription factor that has been
implicated in EMT and has been shown to be a target of Notch
signaling in the AV endocardium (Timmerman et al., 2004).
By contrast to Twist1, Snai1 expression was unaffected by loss
of Bmpr1a in AV endocardium (Fig. 4M,N). Taken together,
these data indicate that Bmp2 signals directly to the cushion
endocardium through the type 1 receptor, Bmpr1a.
Bmp2 regulates multiple genes in the AV
endocardium
NFATc1 is regulated by a calcium-calcineurin pathway and can
translocate to the nucleus upon activation (Crabtree and Olson,
2002). Moreover, NFATc1 expression is upregulated in
activated endothelial cells within the AV canal. At 8.5 dpc,
NFATc1 was present in the endocardium of both wild-type and
Bmp2 CKO mutant embryos (Fig. 5A,B). By 9.5 dpc, NFATc1
was upregulated and nuclear localized in the wild-type AV
cushion endocardium (Fig. 5C), while expression in the Bmp2
CKO mutant embryo AV canal failed to be upregulated (Fig.
5D).
As for the Tie2cre; Bmpr1an/f mutant embryos, expression of
Twist1, normally detected in the AV cushion endocardium and
mesenchyme of wild-type embryos was not detected in the
Bmp2 CKO mutant endocardium (Fig. 5E-H). Bmp signaling
regulates the Msx1 homeobox gene in other developmental
fields (Liu et al., 2005; Vainio et al., 1993). Expression of
Msx1 was detected in the AV endocardium of wild-type
embryos but was absent in the Bmp2 CKO mutant embryos
(Fig. 5I-L). The inhibitory Smad, Smad6, is a negative
regulator of Bmp signaling that is also transcriptionally
regulated by Bmp signaling. Furthermore, Smad6 has been
shown to be a negative regulator of valve development
(Desgrosellier et al., 2005; Galvin et al., 2000; Ishida et al.,
2000). In wild-type embryos, Smad6 was expressed in the AV
endocardium, while in the Bmp2 CKO mutants, Smad6
expression was absent (Fig. 5M,N). This finding uncovers a
negative feedback loop that functions to limit the extent of
endocardial EMT.
During activation of the AV endocardium, VE-cadherin
expression is downregulated in wild-type embryos, but in the
Bmp2 CKO mutant VE-cadherin persists (Fig. 5O,P). A Notch-
Snai1 signaling pathway has been implicated in VE-cadherin
downregulation in AV endocardium (Timmerman et al., 2004).
In the Bmp2 CKO mutants, Notch 1 and Snai1 expression was
reduced compared with wild-type embryos, indicating that the
Notch and Bmp2 signaling pathways cooperate in AV cushion
morphogenesis (Fig. 5Q-V). Taken together, our data indicate
that Bmp2 induces EMT-promoting genes, such as Twist1 and
Snai1, and other genes that restrain EMT such as Smad6.
Moreover, these data indicate that Bmp2 CKO mutants, in
contrast to Bmpr1a-deficient embryos, have defects in Notch-
Snai1 signaling in the AV cushion endocardium (see
Discussion).
Bmp2 regulates Tbx2 in the AV myocardium to
control chamber-specific gene expression
Previous studies in chick embryos had suggested that Bmp2
regulated Tbx2 expression in the developing heart, prompting
us to examine Tbx2 expression in Bmp2 CKO mutants
(Yamada et al., 2000). In wild-type embryos, Tbx2 was
expressed specifically in the AV myocardium, while in the
Bmp2 CKO mutant embryos Tbx2 expression was
undetectable (Fig. 6A,B). By contrast, expression of Tbx5 and
Tbx20 were unaffected by Bmp2 deletion (Fig. 6C-F). These
data indicate that Bmp2 promotes expression of Tbx2 and so
is important to maintain the correct ratio of Tbx genes in the
AV myocardium.
In the AV canal, Tbx2 is known to repress chamber-specific
gene expression. Consistent with this, expression of the
chamber-specific genes Anf, chisel, and connexin 40 was
limited to the ventricular and atrial myocardium in wild-type
embryos (Fig. 7A,C,E,G,I,K). By contrast, in the Bmp2 CKO
mutant embryos, expression of all three chamber-specific
genes was expanded into the AV myocardium (Fig.
7B,D,F,H,J,L). Markers of the AV myocardium, such as Tgf2
and Lef1, were lost in the Bmp2 CKO mutant embryos (Fig.
7M-P). From these findings, we conclude that Bmp2 signaling
directs regionalized myocardial patterning.
Discussion
In this work, we investigated Bmp2 function in cardiac
development by deleting Bmp2 specifically in the AV
myocardium. Our findings provide strong genetic evidence that
Bmp2 is a crucial signal for AV cushion formation in mammals.
We found that Bmp2 promotes cardiac jelly formation and
signals directly to the AV endocardium through the type 1A
receptor, Bmpr1a, to induce EMT. Moreover, our data reveal
that Twist1 is one target of Bmp2 in the AV canal endocardium,
suggesting a novel signaling pathway regulating EMT in valve
formation. In addition, our findings indicate that Bmp2
concurrently regulates myocardial patterning through
regulation of Tbx2 expression. Taken together, our data provide
insights into the mechanisms coordinately regulating cushion
development and myocardial patterning in mammals.
Fig. 6. Tbx expression in Bmp2 CKO mutant embryos at 9.5 dpc. Tbx2 mRNA expression is located in the myocardium of the AV canal in wild-
type embryos (A) but is not present in the mutant (B, indicated by arrow). Other Tbx genes, including Tbx5 and Tbx20, are expressed in the
myocardium of the atrium and ventricle in wild-type embryos (C,E) and also in the Bmp2 CKO mutant embryos (D,F). Arrows denote
hybridization signal. a, atrium; ba, branchial arch; v, ventricle.
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Bmp2 is a crucial inducer of EMT in the AV cushion
The early lethality of the germline Bmp2 null mice has
hampered definitive insight into the role of Bmp2 in AV
cushion development (Zhang and Bradley, 1996). Recently
reported experiments, using the collagen gel invasion assay,
suggested that Bmp2 could substitute for myocardium to
induce EMT in mouse embryos (Sugi et al., 2004). However,
other experiments, also using the collagen gel invasion assay,
showed that Bmp2 functioned only in combination with Tgf3
to promote EMT in chick embryos (Yamagishi et al., 1999).
Furthermore, chick embryos treated with a retrovirus
expressing Noggin caused defects in the OFT but did not affect
the AV canal (Allen et al., 2001). Our data indicate that Bmp2
is the myocardial-derived signal that induces EMT in
mammals. One likely explanation for the different results
obtained from these studies is species-specific differences
between mice and chicks (Camenisch et al., 2002).
Our findings indicate that Bmpr1a is a crucial type 1 receptor
in the AV endocardium to transduce the Bmp signal required
for EMT. Inactivation of Bmpr1a using the Tie2cre transgenic
line disrupted EMT in most mutant embryos examined. The
Tie2cre; Bmpr1a n/f mutant cushion phenotype indicates a
direct requirement for a Bmp signal to induce EMT in the
endocardium. Furthermore, our findings indicate that the
Tie2cre; Bmpr1a n/f mutants have normal cardiac jelly
deposition, as Has2 is expressed and cardiac jelly is deposited
normally. Taken together, these findings provide strong
evidence that the cushion defect in the Bmp2 CKO mutants is
not secondary to failure of cardiac jelly deposition or
disruption of an indirect signal relay mechanism.
It is important to note that Alk2 has also been shown to be
required for EMT in the in-vitro explant system using chick
embryos (Desgrosellier et al., 2005). A constitutively active Alk2
was able to induce EMT, while Alk2 antisera could effectively
inhibit EMT. Furthermore, mouse embryos deficient for Alk2 in
cushion endocardium had a severe defect in AV cushion
morphogenesis (Wang et al., 2005). Our data indicate that the
Notch-Snai1 pathway was intact in the Tie2cre; Bmpr1a n/f mutant
embryos, while this pathway was disrupted in the Alk2 and Bmp2
mutant embryos (this work) (Wang et al., 2005). This indicates
that Bmpr1a and Alk2 may activate distinct pathways in cushion
endocardium. However, other genes such as Msx1, were reduced
in both the Bmpr1a and Alk2 mutants. Taken together, these
findings indicate that signaling through Alk2 and Bmpr1a
activates distinct but overlapping target pathways. Alternatively,
as some (approximately 33%) Tie2cre; Bmpr1a n/f mutants made
AV cushions, it is possible that there is partial redundancy
between type 1 receptors in AV endocardium, similar to that
observed in chondrocytes (Yoon et al., 2005). Future studies will
be required to investigate these questions in more detail.
Previous work investigating Bmp ligands in cardiac
development uncovered considerable functional redundancy.
For example, Bmp7 mutants have no phenotype in the heart as
a result of redundancy with other Bmp ligands (Luo et al.,
1995). Bmp6; Bmp7 double mutants have delayed formation of
the OFT cushions (Kim et al., 2001), while the Bmp5; Bmp7
double mutants have severe defects in cushion formation
(Solloway and Robertson, 1999). Moreover, we found evidence
for overlapping function between Bmp4 and Bmp7 in OFT
development (Liu et al., 2004). By contrast, we have found that
Bmp2 function is essential in the AV canal. It will be important
in the future to investigate the functional relationship of the
distinct classes of Bmp ligands in cushion morphogenesis.
Tgf and Bmp signaling in AV cushion
morphogenesis
Tgf signaling is a crucial signal in avians for EMT in the AV
cushions, as determined by the collagen invasion assay
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Fig. 7. AV myocardium
defect in the Bmp2 CKO
mutants at 9.5 dpc. In wild-
type embryos, chamber-
specific genes, including Anf
(A,C), chisel (E,G) and
connexin 40 (I,K), are
expressed in the
myocardium of the atrium
and ventricle but not in the
AV myocardium (denoted by
arrows). In the Bmp2 CKO
mutant, the expression of
Anf (B,D), chisel (F,H) and
connexin 40 (J,L) is
expanded into the AV canal
myocardium (denoted by
arrows). Tgf2 is expressed
in the AV myocardium in
wild-type embryos (M) but
is significantly reduced in the mutant, as
indicated by arrows (N). Lef1 is also
expressed in the AV myocardium in wild-
type embryos (O) but is significantly reduced
in the mutant (P, indicated by arrow). a,
atrium; v, ventricle.
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(Barnett and Desgrosellier, 2003). However, although Tgf2 is
clearly important for normal cushion development in mice,
EMT can still occur in the Tgf2 null mice (Sanford et al.,
1997). Our data, and the work of Sugi et al. (Sugi et al., 2004),
indicate that much of the function of Tgf has been co-opted
by Bmp signaling in mammals. In mice, current evidence
suggests that Tgf2 expression is regulated by Bmp signaling.
Inactivation of Bmpr1a in myocardium using an MHC cre
transgene resulted in downregulation of Tgf2 expression in
the AV canal (Gaussin et al., 2002). This suggested a cell-
autonomous requirement for Bmp signaling in myocardium to
maintain Tgf2 expression, which was important for the later
aspects of AV cushion development. Furthermore, Bmp2
induces Tgf2 in explants cultured in collagen gel (Sugi et al.,
2004), and Tgf2 expression is off or reduced in the AV
cushions of Bmp2 CKO mutant embryos (this work). Future
experiments will be required to firmly establish the genetic
relationship between Bmp signaling and Tgf2 transcriptional
regulation.
The role of Twist1 in AV cushion EMT
Twist1, first identified in Drosophila as a crucial regulator of
gastrulation and mesoderm formation, has previously been
recognized as an important developmental control gene in
higher vertebrates. Twist1 has been shown to be the gene
mutated in Saethre-Chotzen syndrome, a haploinsufficient
disorder that primarily affects cranial and limb development
(Howard et al., 1997). In mouse embryos, Twist1 is expressed
in presomitic mesoderm, neural crest-derived mesenchyme of
the head and branchial arches and in limb bud mesenchyme
(Gitelman, 1997). Twist1 null mutant embryos had failure of
rostral neural tube closure, most likely as a result of a head
mesenchyme deficiency, but defects in cardiac morphogenesis
were not reported (Chen and Behringer, 1995).
Particularly relevant to the present study is the recent
observation that Twist1 promotes EMT in cancer cells and
facilitates tumor metastasis. Twist1 regulates EMT through a
mechanism involving repression of E-cadherin transcription
(Kang and Massague, 2004; Yang et al., 2004). Our data
indicate that Twist1 expression was lost in both the Bmp2 CKO
and Tie2cre; Bmpr1a n/f mutant embryos. Moreover, we
observed a modest defect in VE-cadherin downregulation in
the Bmp2 and Bmpr1a mutant AV canals. These findings
suggest that Twist1 is an effector of the Bmp-signaling pathway
in the AV canal that promotes endocardial EMT.
We observed only mild defect in VE-cadherin
downregulation, despite loss of Twist1 in the Bmp2 CKO
mutant AV canal. This is probably a result of compensatory
function of the closely related Twist2 gene. There are two Twist
genes in mammals, Twist1 and Twist2, which have redundant
functions in cytokine regulation (Bialek et al., 2004; Li et al.,
1995; Sosic et al., 2003). Further experiments will be required
to investigate this possibility.
It is notable that the Snai1 transcription factor has recently
been shown to be required for AV canal EMT as part of the
Notch signaling pathway (Timmerman et al., 2004). In
Drosophila, Twist and Snai1 are both required for correct
dorsoventral patterning and mesoderm induction as part of the
Dorsal/Twist/Snai1 pathway (Stathopoulos and Levine, 2002).
In vertebrates, both Snai1 and Twist1 have been shown to
promote EMT through inhibition of E-cadherin expression.
Our findings suggest that Bmp and Notch signaling cooperate
to influence VE-cadherin expression. It will be interesting to
investigate the functional relationship of Notch and Bmp
signaling in AV canal EMT in future experiments.
Bmp2 regulates myocardial differentiation
We provide evidence that Bmp2 is upstream of Tbx2 in the AV
myocardium. Our observation that myocardial patterning in the
Tie2cre; Bmpr1a mutants is normal argues against the
hypothesis that an endocardial-derived signal regulates
myocardial patterning. Further experiments will be required to
investigate whether Bmp2 directly regulates Tbx2 expression.
Our findings can be interpreted in the context of recent
Tbx20 inactivation studies that led to conflicting interpretations
of the Bmp2-Tbx2 regulatory relationship. Tbx20 mutant
embryos had expanded Tbx2 expression throughout the
myocardium despite diminished Bmp2 expression, suggesting
that Tbx2 regulation is Bmp2-independent (Cai et al., 2005;
Stennard et al., 2005). Another, independently generated,
Tbx20 null allele resulted in ectopic Bmp2 with resulting
expanded Tbx2 (Singh et al., 2005). Our data support the
conclusion that Bmp2 promotes Tbx2 expression in the AV
myocardium.
It is interesting to note that Tbx20 and Tbx2 are co-expressed
in the AV myocardium, indicating an AV-canal-specific
mechanism that allows Tbx2 to escape Tbx20-imposed
repression. Our data suggest that Bmp2-signaling counters the
repressive activity of Tbx20 in the AV myocardium. Because
Tbx20 is expressed normally in the Bmp2 CKO mutant
embryos, Bmp2 may regulate Tbx20 post-transcriptionally.
Bmp2 may also induce genes that functionally inhibit Tbx20
activity. The precise mechanism underlying this inhibition of
Tbx20 is presently unclear and awaits future experiments.
Fig. 8. Summary of Bmp2 function in the AV canal. Bmp2 signals to
the cushion endocardium through Bmpr1a to promote expression of
genes that support EMT, such as Twist and NFATc1. Bmp2 also
induces expression of Smad6, an inhibitory Smad, to limit the extent
of EMT in the forming AV cushion. An additional function of Bmp2
is to induce expression of Has2, thereby accentuating cardiac jelly
deposition. Finally, within the AV myocardium, Bmp2 signaling is
required for Tbx2 expression, which normally represses expression
of chamber-specific genes in the AV canal. Arrows denote genetic,
not necessarily direct, relationships.
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In conclusion, our findings reveal that Bmp2 is required for
EMT in the mammalian AV canal (see Fig. 8). We have
uncovered a genetic pathway involving the type 1 Bmp
receptor, Bmpr1a, which functions in EMT. Our data also
revealed that Bmp2 signaling is required for normal deposition
of the cardiac jelly. Within the myocardium, Bmp2 functions
upstream of Tbx2 to control regionalized myocardial
patterning.
We thank A. Bradley, P. Soriano and R. Behringer for reagents; A.
McMahon, G. Martin, B. Hogan, R. Maxson, D. Maas, K. Yutzey, R.
Kelley and R. Harvey for in-situ probes; M. Yanagisawa for the Tie2cre
transgenic line; and R. Behringer and Y. Mishina for the Bmpr1a
conditional allele. We thank A. Moon and A. Baldini for comments
on the manuscript and discussions. This work was supported by grants
NIDCR (2R01DE/HD12324-06 and R01DE013509) to J.F.M., and
P30 ES9106-07 to J.F.M. and R.J.S.
References
Allen, S. P., Bogardi, J. P., Barlow, A. J., Mir, S. A., Qayyum, S. R.,
Verbeek, F. J., Anderson, R. H., Francis-West, P. H., Brown, N. A. and
Richardson, M. K. (2001). Misexpression of noggin leads to septal defects
in the outflow tract of the chick heart. Dev. Biol. 235, 98-109.
Armstrong, E. J. and Bischoff, J. (2004). Heart valve development:
endothelial cell signaling and differentiation. Circ. Res. 95, 459-470.
Barnett, J. V. and Desgrosellier, J. S. (2003). Early events in valvulogenesis:
a signaling perspective. Birth Defects Res. C Embryo Today 69, 58-72.
Bartram, U., Molin, D. G., Wisse, L. J., Mohamad, A., Sanford, L. P.,
Doetschman, T., Speer, C. P., Poelmann, R. E. and Gittenberger-de
Groot, A. C. (2001). Double-outlet right ventricle and overriding tricuspid
valve reflect disturbances of looping, myocardialization, endocardial
cushion differentiation, and apoptosis in TGF-beta(2)-knockout mice.
Circulation 103, 2745-2752.
Bialek, P., Kern, B., Yang, X., Schrock, M., Sosic, D., Hong, N., Wu, H.,
Yu, K., Ornitz, D. M., Olson, E. N. et al. (2004). A twist code determines
the onset of osteoblast differentiation. Dev. Cell 6, 423-435.
Cai, C. L., Zhou, W., Yang, L., Bu, L., Qyang, Y., Zhang, X., Li, X.,
Rosenfeld, M. G., Chen, J. and Evans, S. (2005). T-box genes coordinate
regional rates of proliferation and regional specification during
cardiogenesis. Development 132, 2475-2487.
Camenisch, T. D., Molin, D. G., Person, A., Runyan, R. B., Gittenberger-
de Groot, A. C., McDonald, J. A. and Klewer, S. E. (2002). Temporal and
distinct TGFbeta ligand requirements during mouse and avian endocardial
cushion morphogenesis. Dev. Biol. 248, 170-181.
Chen, Z. F. and Behringer, R. R. (1995). twist is required in head
mesenchyme for cranial neural tube morphogenesis. Genes Dev. 9, 686-699.
Crabtree, G. R. and Olson, E. N. (2002). NFAT signaling: choreographing
the social lives of cells. Cell 109, S67-S79.
Desgrosellier, J. S., Mundell, N. A., McDonnell, M. A., Moses, H. L. and
Barnett, J. V. (2005). Activin receptor-like kinase 2 and Smad6 regulate
epithelial-mesenchymal transformation during cardiac valve formation. Dev.
Biol. 280, 201-210.
Eisenberg, L. M. and Markwald, R. R. (1995). Molecular regulation of
atrioventricular valvuloseptal morphogenesis. Circ. Res. 77, 1-6.
Galvin, K. M., Donovan, M. J., Lynch, C. A., Meyer, R. I., Paul, R. J.,
Lorenz, J. N., Fairchild-Huntress, V., Dixon, K. L., Dunmore, J. H.,
Gimbrone, M. A. et al. (2000). A role for smad6 in development and
homeostasis of the cardiovascular system. Nat. Genet. 24, 171-174.
Gaussin, V., Van de Putte, T., Mishina, Y., Hanks, M. C., Zwijsen, A.,
Huylebroeck, D., Behringer, R. R. and Schneider, M. D. (2002).
Endocardial cushion and myocardial defects after cardiac myocyte-specific
conditional deletion of the bone morphogenetic protein receptor ALK3.
Proc. Natl. Acad. Sci. USA 99, 2878-2883.
Gitelman, I. (1997). Twist protein in mouse embryogenesis. Dev. Biol. 189,
205-214.
Habets, P. E., Moorman, A. F., Clout, D. E., van Roon, M. A., Lingbeek,
M., van Lohuizen, M., Campione, M. and Christoffels, V. M. (2002).
Cooperative action of Tbx2 and Nkx2.5 inhibits ANF expression in the
atrioventricular canal: implications for cardiac chamber formation. Genes
Dev. 16, 1234-1246.
Harrelson, Z., Kelly, R. G., Goldin, S. N., Gibson-Brown, J. J., Bollag, R.
J., Silver, L. M. and Papaioannou, V. E. (2004). Tbx2 is essential for
patterning the atrioventricular canal and for morphogenesis of the outflow
tract during heart development. Development 131, 5041-5052.
Howard, T. D., Paznekas, W. A., Green, E. D., Chiang, L. C., Ma, N.,
Ortiz de Luna, R. I., Garcia Delgado, C., Gonzalez-Ramos, M., Kline,
A. D. and Jabs, E. W. (1997). Mutations in TWIST, a basic helix-loop-
helix transcription factor, in Saethre-Chotzen syndrome. Nat. Genet. 15,
36-41.
Hurlstone, A. F., Haramis, A. P., Wienholds, E., Begthel, H., Korving, J.,
Van Eeden, F., Cuppen, E., Zivkovic, D., Plasterk, R. H. and Clevers,
H. (2003). The Wnt/beta-catenin pathway regulates cardiac valve formation.
Nature 425, 633-637.
Ishida, W., Hamamoto, T., Kusanagi, K., Yagi, K., Kawabata, M.,
Takehara, K., Sampath, T. K., Kato, M. and Miyazono, K. (2000).
Smad6 is a Smad1/5-induced smad inhibitor. Characterization of bone
morphogenetic protein-responsive element in the mouse Smad6 promoter.
J. Biol. Chem. 275, 6075-6079.
Kang, Y. and Massague, J. (2004). Epithelial-mesenchymal transitions: twist
in development and metastasis. Cell 118, 277-279.
Kim, R. Y., Robertson, E. J. and Solloway, M. J. (2001). Bmp6 and Bmp7
are required for cushion formation and septation in the developing mouse
heart. Dev. Biol. 235, 449-466.
Kisanuki, Y. Y., Hammer, R. E., Miyazaki, J., Williams, S. C., Richardson,
J. A. and Yanagisawa, M. (2001). Tie2-Cre transgenic mice: a new model
for endothelial cell-lineage analysis in vivo. Dev. Biol. 230, 230-242.
Krug, E. L., Runyan, R. B. and Markwald, R. R. (1985). Protein extracts
from early embryonic hearts initiate cardiac endothelial cytodifferentiation.
Dev. Biol. 112, 414-426.
Li, L., Cserjesi, P. and Olson, E. N. (1995). Dermo-1: a novel twist-related
bHLH protein expressed in the developing dermis. Dev. Biol. 172, 280-292.
Liebner, S., Cattelino, A., Gallini, R., Rudini, N., Iurlaro, M., Piccolo, S.
and Dejana, E. (2004). Beta-catenin is required for endothelial-
mesenchymal transformation during heart cushion development in the
mouse. J. Cell Biol. 166, 359-367.
Liu, W., Selever, J., Wang, D., Lu, M. F., Moses, K. A., Schwartz, R. J. and
Martin, J. F. (2004). Bmp4 signaling is required for outflow-tract septation
and branchial-arch artery remodeling. Proc. Natl. Acad. Sci. USA 101, 4489-
4494.
Liu, W., Selever, J., Murali, D., Sun, X., Brugger, S. M., Ma, L., Schwartz,
R. J., Maxson, R., Furuta, Y. and Martin, J. F. (2005). Threshold-specific
requirements for Bmp4 in mandibular development. Dev. Biol. 283, 282-
293.
Lu, M. F., Pressman, C., Dyer, R., Johnson, R. L. and Martin, J. F. (1999).
Function of Rieger syndrome gene in left-right asymmetry and craniofacial
development. Nature 401, 276-278.
Luo, G., Hofmann, C., Bronckers, A. L., Sohocki, M., Bradley, A. and
Karsenty, G. (1995). BMP-7 is an inducer of nephrogenesis, and is also
required for eye development and skeletal patterning. Genes Dev. 9, 2808-
2820.
Lyons, K. M., Pelton, R. W. and Hogan, B. L. (1990). Organogenesis and
pattern formation in the mouse: RNA distribution patterns suggest a role for
bone morphogenetic protein-2A (BMP-2A). Development 109, 833-844.
Ma, L. and Martin, J. F. (2005). Generation of a Bmp2 conditional null allele.
Genesis 42, 203-206.
Mishina, Y., Suzuki, A., Ueno, N. and Behringer, R. R. (1995). Bmpr
encodes a type I bone morphogenetic protein receptor that is essential for
gastrulation during mouse embryogenesis. Genes Dev. 9, 3027-3037.
Mishina, Y., Hanks, M. C., Miura, S., Tallquist, M. D. and Behringer, R.
R. (2002). Generation of Bmpr/Alk3 conditional knockout mice. Genesis
32, 69-72.
Moses, K. A., De Mayo, F., Braun, R. M., Reecy, J. L. and Schwartz, R.
J. (2001). Embryonic expression of an Nkx2-5/Cre gene using ROSA26
reporter mice. Genesis 31, 176-180.
Nagy, A. (2000). Cre recombinase: the universal reagent for genome tailoring.
Genesis 26, 99-109.
Plageman, T. F. and Yutzey, K. E. (2005). T-box genes and heart
development: Putting the “T” in heart. Dev. Dyn. 232, 11-20.
Runyan, R. B. and Markwald, R. R. (1983). Invasion of mesenchyme into
three-dimensional collagen gels: a regional and temporal analysis of
interaction in embryonic heart tissue. Dev. Biol. 95, 108-114.
Sanford, L. P., Ormsby, I., Gittenberger-de Groot, A. C., Sariola, H.,
Friedman, R., Boivin, G. P., Cardell, E. L. and Doetschman, T. (1997).
TGFbeta2 knockout mice have multiple developmental defects that are non-
Development 132 (24) Research article
D
ev
el
op
m
en
t
5611Bmp2 in epithelial-mesenchymal transitionDevelopment and disease
overlapping with other TGFbeta knockout phenotypes. Development 124,
2659-2670.
Schultheiss, T. M., Burch, J. B. and Lassar, A. B. (1997). A role for bone
morphogenetic proteins in the induction of cardiac myogenesis. Genes Dev.
11, 451-462.
Singh, M. K., Christoffels, V. M., Dias, J. M., Trowe, M. O., Petry, M.,
Schuster-Gossler, K., Burger, A., Ericson, J. and Kispert, A. (2005).
Tbx20 is essential for cardiac chamber differentiation and repression of
Tbx2. Development 132, 2697-2707.
Solloway, M. J. and Robertson, E. J. (1999). Early embryonic lethality in
Bmp5; Bmp7 double mutant mice suggests functional redundancy within
the 60A subgroup. Development 126, 1753-1768.
Sosic, D., Richardson, J. A., Yu, K., Ornitz, D. M. and Olson, E. N. (2003).
Twist regulates cytokine gene expression through a negative feedback loop
that represses NF-kappaB activity. Cell 112, 169-180.
Stathopoulos, A. and Levine, M. (2002). Dorsal gradient networks in the
Drosophila embryo. Dev. Biol. 246, 57-67.
Stennard, F. A., Costa, M. W., Lai, D., Biben, C., Furtado, M. B., Solloway,
M. J., McCulley, D. J., Leimena, C., Preis, J. I., Dunwoodie, S. L. et al.
(2005). Murine T-box transcription factor Tbx20 acts as a repressor during
heart development, and is essential for adult heart integrity, function and
adaptation. Development 132, 2451-2462.
Sugi, Y., Yamamura, H., Okagawa, H. and Markwald, R. R. (2004). Bone
morphogenetic protein-2 can mediate myocardial regulation of
atrioventricular cushion mesenchymal cell formation in mice. Dev. Biol.
269, 505-518.
Takeuchi, J. K., Mileikovskaia, M., Koshiba-Takeuchi, K., Heidt, A. B.,
Mori, A. D., Arruda, E. P., Gertsenstein, M., Georges, R., Davidson, L.,
Mo, R. et al. (2005). Tbx20 dose-dependently regulates transcription factor
networks required for mouse heart and motoneuron development.
Development 132, 2463-2474.
Timmerman, L. A., Grego-Bessa, J., Raya, A., Bertran, E., Perez-Pomares,
J. M., Diez, J., Aranda, S., Palomo, S., McCormick, F., Izpisua-
Belmonte, J. C. et al. (2004). Notch promotes epithelial-mesenchymal
transition during cardiac development and oncogenic transformation. Genes
Dev. 18, 99-115.
Trumpp, A., Depew, M. J., Rubenstein, J. L., Bishop, J. M. and Martin,
G. R. (1999). Cre-mediated gene inactivation demonstrates that FGF8 is
required for cell survival and patterning of the first branchial arch. Genes
Dev. 13, 3136-3148.
Vainio, S., Karavanova, I., Jowett, A. and Thesleff, I. (1993). Identification
of BMP-4 as a signal mediating secondary induction between epithelial and
mesenchymal tissues during early tooth development. Cell 75, 45-58.
von Bubnoff, A. and Cho, K. W. (2001). Intracellular BMP signaling
regulation in vertebrates: pathway or network? Dev. Biol. 239, 1-14.
Wang, J., Sridurongrit, S., Dudas, M., Thomas, P., Nagy, A., Schneider,
M. D., Epstein, J. A. and Kaartinen, V. (2005). Atrioventricular cushion
transformation is mediated by ALK2 in the developing mouse heart. Dev.
Biol. 286, 299-310.
Yamada, M., Revelli, J. P., Eichele, G., Barron, M. and Schwartz, R. J.
(2000). Expression of chick Tbx-2, Tbx-3, and Tbx-5 genes during early
heart development: evidence for BMP2 induction of Tbx2. Dev. Biol. 228,
95-105.
Yamagishi, T., Nakajima, Y., Miyazono, K. and Nakamura, H. (1999).
Bone morphogenetic protein-2 acts synergistically with transforming growth
factor-beta3 during endothelial-mesenchymal transformation in the
developing chick heart. J. Cell Physiol. 180, 35-45.
Yang, J., Mani, S. A., Donaher, J. L., Ramaswamy, S., Itzykson, R. A.,
Come, C., Savagner, P., Gitelman, I., Richardson, A. and Weinberg, R.
A. (2004). Twist, a master regulator of morphogenesis, plays an essential
role in tumor metastasis. Cell 117, 927-939.
Yoon, B. S., Ovchinnikov, D. A., Yoshii, I., Mishina, Y., Behringer, R. R.
and Lyons, K. M. (2005). Bmpr1a and Bmpr1b have overlapping functions
and are essential for chondrogenesis in vivo. Proc. Natl. Acad. Sci. USA 102,
5062-5067.
Zhang, H. and Bradley, A. (1996). Mice deficient for BMP2 are nonviable
and have defects in amnion/chorion and cardiac development. Development
122, 2977-2986.
D
ev
el
op
m
en
t
